Progesterone-only pills are recommended for women who:

Severe cystic acne is a deep, inflammatory form of acne vulgaris that can lead to scarring and significant psychosocial distress if not properly managed. Isotretinoin (Accutane) is one of the most effective treatments for refractory severe acne but requires strict monitoring due to its teratogenicity and potential systemic side effects. Initiation of this medication involves specialized prescribing programs and careful risk evaluation. Referral to a specialist ensures safe and appropriate management.

Rationale:
A. Obtaining a thyroid stimulating hormone (TSH) level is not a prerequisite for initiating Isotretinoin (Accutane) therapy. While baseline labs such as liver function tests and lipid profiles are commonly required, thyroid function testing is not routinely indicated. Additionally, isotretinoin initiation requires structured monitoring and prescribing under appropriate protocols, typically managed by dermatology.

B. Referral to a dermatologist is the most appropriate action because Isotretinoin (Accutane) requires specialized oversight due to its high-risk profile, including severe teratogenicity and potential psychiatric and metabolic side effects. Dermatologists are trained to manage enrollment in risk management programs, monitor laboratory values, and ensure safe use, especially in reproductive-age females.

C. Stating that isotretinoin is contraindicated in all females is incorrect because it is not absolutely contraindicated; rather, it is strictly controlled in females of reproductive potential. With proper enrollment in pregnancy prevention programs and adherence to contraception requirements, it can be safely prescribed. Oral tetracyclines are not appropriate substitutes for severe cystic acne and are also contraindicated in pregnancy.

D. Severe cystic acne does require treatment escalation when first-line therapies fail, as untreated disease can result in permanent scarring and significant psychological impact. Minimizing the condition as “typical” ignores the progressive and potentially disfiguring nature of severe acne. Escalation to advanced therapies such as Isotretinoin (Accutane) is standard of care when indicated.

Monoamine oxidase inhibitors (MAOIs) are a class of antidepressants used primarily in treatment-resistant depression and some anxiety disorders. They work by increasing levels of key monoamine neurotransmitters in the brain, including serotonin, norepinephrine, and dopamine. This is achieved through inhibition of the enzyme responsible for breaking down these neurotransmitters. Understanding this mechanism is essential because it also explains their significant food and drug interaction risks.

Rationale:
A. Monoamine oxidase inhibitors do not work by inhibiting dopamine production in the hypothalamus or limbic system. Instead, they act after neurotransmitters are released, affecting their breakdown rather than their synthesis. Dopamine production itself is not directly suppressed by this medication class.

B. Inhibition of 5-HT2 receptors on the postsynaptic membrane is the mechanism of atypical antipsychotics, not MAOIs. Monoamine oxidase inhibitors do not exert their primary effect through receptor blockade but through preventing enzymatic degradation of monoamines. This option describes a different pharmacologic class entirely.

C. Inhibition of serotonin (5-HT) and norepinephrine reuptake into the presynaptic neuron is the mechanism of action of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). MAOIs do not block reuptake transporters; instead, they prevent breakdown of neurotransmitters within the neuron and synaptic cleft.

D. Monoamine oxidase inhibitors work by inhibiting the monoamine oxidase enzyme responsible for breaking down dopamine, norepinephrine, and serotonin in the brain. This leads to increased availability and prolonged action of these neurotransmitters in the synaptic cleft. This mechanism explains both their antidepressant effects and their high risk for serious drug and food interactions.